Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 5/20 | 0.45 |
| ▸ | ATM | Q13315 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29350014 | 0.86 | HCRTR1 (0.57) | KMT2AMEN1ALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL333676 | 0.86 | HCRTR1 (0.57) | KMT2AMEN1ALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL11601663 | 0.79 | HCRTR1 (0.58) | KMT2AMEN1RAB9AALDH1A1MAPK1 | |
| Phenylglyoxal SCHEMBL8060257 | 0.79 | MAPK1 (0.69) | KMT2AMEN1RAB9AALDH1A1MAPK1 | |
| SCHEMBL720460 | 0.76 | RAB9A (0.67) | KMT2AMEN1RAB9AALDH1A1MAPK1 | |
| SCHEMBL30033997 | 0.76 | RAB9A (0.67) | KMT2AMEN1RAB9AALDH1A1MAPK1 | |
| SCHEMBL29483366 | 0.75 | NPC1 (0.71) | KMT2AMEN1RAB9AALDH1A1MAPK1 | |
| SCHEMBL7631355 | 0.75 | NPC1 (0.71) | KMT2AMEN1RAB9AALDH1A1MAPK1 | |
| Hydrochloric Acid SCHEMBL8729799 | 0.74 | RAB9A (0.65) | KMT2AMEN1RAB9AALDH1A1MAPK1 | |
| Bicarbonate SCHEMBL27740096 | 0.74 | RAB9A (0.65) | KMT2AMEN1RAB9AALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2563896-A2 | DELIVERY PARTICLES | The Procter & Gamble Company (US) | 2013-03-06 | — | — | EP | claimed |
| US-8071214-B2 | Particle with selected permeance wall | APPLETON PAPERS INC. (US) | 2011-12-06 | — | — | US | claimed |
| US-20110268778-A1 | DELIVERY PARTICLES | THE PROCTER & GAMBLE COMPANY | 2011-11-03 | — | — | US | claimed |
| WO-2010079466-A2 | DELIVERY PARTICLES | THE PROCTER & GAMBLE COMPANY (US) | 2010-07-15 | — | — | WO | claimed |
| WO-2009134234-A1 | PARTICLE WITH SELECTED PERMEANCE WALL | APPLETON PAPERS INC. (US) | 2009-11-05 | — | — | WO | claimed |
| US-20090274907-A1 | Particle with selected permeance wall | APPLETON PAPERS INC. (US) | 2009-11-05 | — | — | US | claimed |
| US-11931711-B2 | Microcapsule clusters | ENCAPSYS, LLC (US) | 2024-03-19 | — | — | US | disclosed |
| US-20230264161-A1 | Microcapsule Clusters | ENCAPSYS LLC (US) | 2023-08-24 | — | — | US | disclosed |
| EP-3946710-A1 | MICROCAPSULE CLUSTERS | Encapsys, LLC (US) | 2022-02-09 | — | — | EP | disclosed |
| CN-113710357-A | Method for preparing polymer capsules | 宝洁公司 | 2021-11-26 | — | — | CN | disclosed |
| US-11180714-B2 | Controlled release microcapsules | ENCAPSYS, LLC (US) | 2021-11-23 | — | — | US | disclosed |
| CN-113660929-A | Polymer capsules | 宝洁公司 | 2021-11-16 | — | — | CN | disclosed |
| CN-113631249-A | Device and method for producing an emulsion | 宝洁公司 | 2021-11-09 | — | — | CN | disclosed |
| US-9714396-B2 | Controlled release dual walled microcapsules | ENCAPSYS LLC (US) | 2017-07-25 | — | — | US | disclosed |
| US-9714397-B2 | Controlled release microcapsules | ENCAPSYS LLC (US) | 2017-07-25 | — | — | US | disclosed |
| US-20160108340-A1 | CONTROLLED RELEASE MICROCAPSULES | ENCAPSYS LLC (US) | 2016-04-21 | — | — | US | disclosed |
| EP-2563896-A2 | DELIVERY PARTICLES | The Procter & Gamble Company (US) | 2013-03-06 | — | — | EP | disclosed |
| US-8071214-B2 | Particle with selected permeance wall | APPLETON PAPERS INC. (US) | 2011-12-06 | — | — | US | disclosed |
| US-20110268778-A1 | DELIVERY PARTICLES | THE PROCTER & GAMBLE COMPANY | 2011-11-03 | — | — | US | disclosed |
| WO-2010079466-A2 | DELIVERY PARTICLES | THE PROCTER & GAMBLE COMPANY (US) | 2010-07-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110268778-A1 | DELIVERY PARTICLES | LIPA, CHMP4B, ABCB4 | KMT2A 4783/4885MEN1 1316/4885RAB9A 2217/4885 |
| US-11180714-B2 | Controlled release microcapsules | NSF, CRH, CHMP4B | KMT2A 4847/4885MEN1 208/4885RAB9A 1400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.